Form 4: Cencora Director Clyburn Receives Restricted Stock Units

Director Frank Clyburn receives restricted stock units in Cencora, Inc.

Summary

• On March 6, 2025, Frank Clyburn, a director of Cencora, Inc., acquired 789 shares of common stock through an annual grant of restricted stock units.
• These restricted stock units were received for no consideration and will vest 100% on the first anniversary of the grant date.
• Following the transaction, Clyburn directly owns 1,157 shares of Cencora common stock.

Sentiment

Score: 7

Explanation: The document indicates a standard compensation practice, which is generally viewed neutrally to positively as it aligns director interests with shareholders.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Grants of restricted stock units to directors are a common practice in publicly traded companies to incentivize and align their interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash, stock options, and restricted stock units.
• The specific terms of the grant, such as the vesting schedule and the number of units granted, are typically determined by the company's compensation committee and are benchmarked against industry peers.
• Comparable companies in the pharmaceutical distribution industry, such as McKesson and Cardinal Health, also utilize equity-based compensation for their directors.

Stakeholder Impact

• Shareholders may view the grant of restricted stock units positively as it aligns the director's interests with the long-term performance of the company.

Key Dates